Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
HK:2496
Stock Latest News
Company Announcements
Wuhan YZY Biopharma Sets Board Meeting to Approve Interim 2026 Results
10d ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma AGM Approves 2025 Results, Profit Plan and Auditor Reappointment
2M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Sets 2026 AGM to Approve 2025 Results and Share Issuance Mandate
3M ago
2496
Premium
Company Announcements
YZY Biopharma’s M701 Shows Promising Phase III Data Ahead of 2026 ASCO
3M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Reshapes Supervisory Committee With New Employee Representative
3M ago
2496
Premium
Company Announcements
YZY Biopharma’s Lead Cancer Bispecific M701 Wins NMPA NDA Acceptance
4M ago
2496
Premium
Company Announcements
YZY Biopharma’s M701 Data Secured for High-Profile ASCO 2026 Presentations
4M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Completes Full Circulation of H Shares to Boost Market Liquidity
5M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Swings to Net Liabilities as 2025 Revenue Falls
5M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Sets March Board Meeting to Approve 2025 Final Results
5M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Confirms Land and Building Transfer Will Not Affect R&D or Commercial Plans
7M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Wins HKEX Approval for Full H-Share Circulation of 35% Stake
7M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Wins FDA IND Approval for Bispecific Antibody M701 in Malignant Pleural Effusion
7M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Clears CSRC Filing for H Share Full Circulation Plan
7M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma to Transfer Wuhan Industrial Land and Building for RMB36.88 Million
7M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Reshapes Supervisory Committee With New Employee Representative Supervisor
8M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Wins NMPA IND Nod for Hemlibra Biosimilar Y225 and Deepens Antibody R&D Push
8M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma’s M701 Shows Promising Results in Phase II Trial
9M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Reports Promising Phase II Results for M701 in Treating Malignant Pleural Effusion
10M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Announces Change in Supervisory Committee
11M ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Reports Interim 2025 Financial Results Amid R&D Focus
1y ago
2496
Premium
Company Announcements
Wuhan YZY Biopharma Schedules Board Meeting to Review Interim Results
1y ago
2496
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
